From: Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas
Direct sequencing
Agreement
V600E
Wild type
STAfragment analysis
V600E Mutant
118
1
κ, 0.98(95 % CI, 0.98 to 0.99)
wild type
0
40